Your browser doesn't support javascript.
loading
Incorporation of lapatinib into human serum albumin nanoparticles with enhanced anti-tumor effects in HER2-positive breast cancer.
Wan, Xu; Zheng, Xiaoyao; Pang, Xiaoying; Zhang, Zheming; Zhang, Qizhi.
  • Wan X; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, People's Republic of China.
  • Zheng X; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, People's Republic of China.
  • Pang X; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, People's Republic of China.
  • Zhang Z; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, People's Republic of China.
  • Zhang Q; Department of Pharmaceutics, School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, Shanghai 201203, People's Republic of China. Electronic address: qzzhang@fudan.edu.cn.
Colloids Surf B Biointerfaces ; 136: 817-27, 2015 Dec 01.
Article en En | MEDLINE | ID: mdl-26539808
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinazolinas / Neoplasias de la Mama / Albúmina Sérica / Receptor ErbB-2 / Nanopartículas / Antineoplásicos Límite: Female / Humans Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinazolinas / Neoplasias de la Mama / Albúmina Sérica / Receptor ErbB-2 / Nanopartículas / Antineoplásicos Límite: Female / Humans Idioma: En Año: 2015 Tipo del documento: Article